Análogos de la somatostatina en el tratamiento de la retinopatía diabética

the diabetic retinopathy is an important health problem due to visual disability provoked. the choice treatment still remains the laser photocoagulation, but sometimes there is advanced ways in which the response is poor and the course is torpid. other alternatives of treatment are look for to improve the course including the steroids and anti-angiogenic. the aim of present review was to regroup the current information on this group of drugs (somatostatin analogues), which has a anti-angiogenic effect and used in the treatment of proliferative diabetic retinopathy and the diabetic macular edema. the somatostatin analogues have shown to be effective, mainly in the control of hemorrhagic and proliferative phenomena and to also improve the integrity of the hematoretinal barrier, offer an alternative of treatment for diabetic macular edema, mainly when the response to laser is not favorable.